Monash University researchers alongside key partner Halozyme Therapeutics have reported findings in support of shifting the way anti-cancer ...

The FDA approved a subcutaneous injection version of Bristol Myers Squibb nivolumab and hyaluronidase-nvhy for the treatment of several cancers including melanoma, non-small cell lung cancer and renal ...

Please provide your email address to receive an email when new articles are posted on . Vascular occlusion occurs when the filler is unintentionally injected into a blood vessel, causing embolic ...

The Food and Drug Administration (FDA) has approved Tecentriq Hybreza ™ (atezolizumab and hyaluronidase-tqjs) for subcutaneous (SC) injection, for all the approved adult indications of intravenous ...

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...

Vascular occlusion—the disruption of blood flow in arteries—on ultrasound from hyaluronic acid fillers. This ultrasound image shows absent blood flow in a segment of an artery of the lip. Cosmetic ...

Patients who received Vyvgart Hytrulo experienced a longer time to clinical deterioration compared with those who received placebo. The Food and Drug Administration (FDA) has approved Vyvgart ® ...

Opinions expressed by Digital Journal contributors are their own. Gaining worldwide recognition is a huge accomplishment that only a few medical experts reach. It’s not just about having excellent ...